CSIMarket
 


Biolase Inc   (BIOL)
Other Ticker:  
 

Biolase Inc 's Long Term Debt to Equity

BIOL's quarterly Long Term Debt to Equity and Long Term Debt, Equity growth


In Spite of the long-term debt repayement of -5%, in III Quarter 2023 ,Long Term Debt to Equity deteriorated to 34.06 reached a new all-time high.

Within Medical Equipment & Supplies industry in the third quarter 2023, 105 other companies have achieved lower Long Term Debt to Equity than Biolase Inc in the III Quarter 2023. While Long Term Debt to Equity total ranking has deteriorated compared to the second quarter 2023 from 2048 to 2671 .

Explain Long Term Debt to Equity Ratio?
How much Long Term Debt BIOL´s has?
What is the structure of BIOL´s Equity?


BIOL Long Term Debt to Equity (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity Change -97.6 % -69.37 % -60.4 % -80.61 % -54.3 %
Y / Y Long Term Debt Change -11.62 % -6.5 % -8.56 % -3.76 % 5.61 %
Long Term Debt to Equity MRQ 34.06 1.8 1.53 2.68 0.92
BIOL's Total Ranking # 2671 # 2048 # 1881 # 2496 # 1880
Seq. Equity Change -94.99 % -18.84 % 66.86 % -64.72 % -35.89 %
Seq. Long Term Debt Change -5 % -4.75 % -4.55 % 2.33 % 0.49 %



Long Term Debt to Equity third quarter 2023 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 106
Healthcare Sector # 332
Overall Market # 2671


Long Term Debt to Equity Statistics
High Average Low
34.06 2.01 0
(Sep 30 2023)   (Sep 30 2016)




Financial Statements
Biolase Inc 's Equity $ 0 Millions Visit BIOL's Balance sheet
Biolase Inc 's Long Term Debt $ 11 Millions Visit BIOL's Balance sheet
Source of BIOL's Sales Visit BIOL's Sales by Geography


Cumulative Biolase Inc 's Long Term Debt to Equity

BIOL's Long Term Debt to Equity for the trailling 12 Months

BIOL Long Term Debt to Equity

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity TTM Growth -97.6 % -69.37 % -60.4 % -80.61 % -54.3 %
Y / Y Long Term Debt TTM Growth -11.62 % -6.5 % -8.56 % -3.76 % 5.61 %
Long Term Debt to Equity TTM 2.44 1.5 1.05 0.86 0.65
Total Ranking TTM # 208 # 88 # 86 # 2525 # 0
Seq. Equity TTM Growth -94.99 % -18.84 % 66.86 % -64.72 % -35.89 %
Seq. Long Term Debt TTM Growth -5 % -4.75 % -4.55 % 2.33 % 0.49 %


On the trailing twelve months basis Despite of the long-term debt repayement of -5% in the trailing twelve months ending in III Quarter 2023, Long Term Debt to Equity improved to 2.44, above Biolase Inc 's average Long Term Debt to Equity.
Long Term Debt to Equity is the average cumulative value over the last four quarters.

Among companies in the Medical Equipment & Supplies industry 14, during the past 12 months, other companies have achieved lower Long Term Debt to Equity than Biolase Inc . While Long Term Debt to Equity total ranking has deteriorated during the twelve months ending in the III Quarter 2023, compared to the prior period, from 88 to 208.

Explain Long Term Debt to Equity Ratio?
How much Long Term Debt BIOL´s has?
What is the structure of BIOL´s Equity?

TTM Long Term Debt to Equity Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 15
Healthcare Sector # 47
Within the Market # 208


trailing twelve months Long Term Debt to Equity Statistics
High Average Low
3.73 0.9 0
(Dec 31 2019)   (Mar 31 2018)




Companies with similar Long Term Debt to Equity in the quarter ending Sep 30 2023, within Medical Equipment & Supplies Industry Long Term Debt to EquitySep 30 2023 MRQ Long Term DebtSep 30 2023 MRQ Equity
Mimedx Group Inc   36.82 $ 48.966  Millions$ 1.330  Millions
Biolase Inc   34.06 $ 11.307  Millions$ 0.332  Millions
The Beauty Health Company  8.20 $ 737.315  Millions$ 89.957  Millions

Date modified: 2023-11-12T10:54:19+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com